HomeCoronary diseaseChronic Ischemic cardiopathy

Chronic Ischemic cardiopathy

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization....

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL)...

FLAVOUR Trial Substudy: FFR or IVUS in the Assessment of Diabetic Patients

Patients with diabetes often present with more complex coronary artery disease compared to non-diabetic patients, with a...

Mechanical Circulatory Support in Complex Anatomies and Severe Deterioration of Left Ventricular Function

Severe coronary artery disease (CAD) frequently causes left ventricular function deterioration, and is often treated with myocardial...

Early and Late Outcomes with the ABSORB Bioresorbable Scaffold

Coronary angioplasty with drug-eluting stents (DES) is associated with a 2-3% annual incidence of stent-related events, a...

Coronary Sinus Reducer for Refractory Angina: Notes from the REDUCER-I Study

Refractory angina is defined as the presence of ischemic symptoms that cannot be controlled through optimal medical...

Discordance between Physiology and Imaging Guided PCI in Intermediate Coronary Lesions: Who to trust?

As regards intermediate coronary lesion intervention, physiological assessment is essential for culprit lesion identification and clinical decision...